Hyaluronic acid is used to reduce dry eye symptoms by lubricating the eyes, and it's also injected into joints to reduce arthritis pain and into the skin to add volume and reduce wrinkles.[2] Restasis is currently approved and in use across 32 indications[4].[1]
Restasis is one of 462 small molecule programs targeting Arthropathy. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
778 competitors in Osteoarthritis
Restasis
Epidiolex
Toradol
Cataflam
Bayer Aspirin
Platelet Rich Plasma
Voltaren
Enbrel
Paracetamol
Chirocaine
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details